NCT01209533View on ClinicalTrials.gov

Inhaled Iloprost in Mild Asthma

EARLY_PHASE1CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

September 30, 2010

Primary Completion Date

July 31, 2011

Study Completion Date

July 31, 2011

Conditions
Asthma
Interventions
DRUG

Iloprost

Inhaled iloprost 2.5 or 5 micrograms four times daily for 14 days

Trial Locations (1)

37064

Vanderbilt University Medical Center, Nashville

Sponsors

Collaborators (1)

Actelion
All Listed Sponsors
collaborator

Actelion

INDUSTRY

lead

Vanderbilt University

OTHER

NCT01209533 - Inhaled Iloprost in Mild Asthma | Biotech Hunter | Biotech Hunter